APTEVO THERAPEUTICS INC (APVO:NASDAQ)

$2.46 0.05 (2.0747%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 85

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed APTEVO THERAPEUTICS INC (APVO:NASDAQ) News Sources

Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

13-05-2026

yahoo.com

external link

All You Need to Know About Aptevo Therapeutics (APVO) Rating Upgrade to Buy

20-05-2026

yahoo.com

external link

Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing

27-05-2026

yahoo.com

external link

Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer

28-05-2026

yahoo.com

external link

APVO: Initiating Coverage of Aptevo Therapeutics Inc.; Unlocking the Next Generation of Multispecific Immune Engagement

16-06-2026

yahoo.com

external link

Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors

30-06-2026

yahoo.com

external link

Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone

27-07-2026

yahoo.com

external link

Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds

12-08-2026

yahoo.com

external link

Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results

14-08-2026

yahoo.com

external link

APVO: Focusing on Three Key Areas of Development

24-08-2026

yahoo.com

external link

APTEVO THERAPEUTICS INC (APVO:NASDAQ) Sentiment Trend

0 25 50 75 100 87 83 90 84 91 89 86 74 72 89 13-05-2026 20-05-2026 27-05-2026 28-05-2026 16-06-2026 30-06-2026 27-07-2026 12-08-2026 14-08-2026 24-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

APTEVO THERAPEUTICS INC (APVO:NASDAQ) FAQs

toggle

What is the current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ) is $2.46.


toggle

APTEVO THERAPEUTICS INC (APVO:NASDAQ) absolute price change since previous trading day?

The absolute price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is $0.05.


toggle

APTEVO THERAPEUTICS INC (APVO:NASDAQ) percentage price change since previous trading day?

The percentage price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is 2.0747%.


toggle

What is the most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is 85 out of 100.


toggle

What is the most recent average sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The most recent sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is .


SEC-8K** Filing Available For APTEVO THERAPEUTICS INC (APVO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

APLT (Applied Therapeutics Inc)
APM (Aptorum Group Ltd Cl A)
APLM (Apollomics Inc Cl A)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.